Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
AMC Global Media
AMCX
$522M
| $2.94M | ﹤0.01% |
63,118
+57,325
| +990% | +$2.93M |
|
3427
Xometry
XMTR
$5.39B
| $2.94M | ﹤0.01% |
50,998
-65,439
| -56% | -$4.53M |
|
3428
Anterix
ATEX
$1.81B
| $2.94M | ﹤0.01% |
48,393
+19,984
| +70% | +$1.17M |
|
3429
PUT
Constellation Brands
STZ
$22.3B
| $2.93M | ﹤0.01% |
+13,900
| New | +$3.03M |
|
|
DRAYU
3430
DELISTED
Macondray Capital Acquisition Corp. I Unit
DRAYU
| $2.92M | ﹤0.01% |
+292,500
| New | +$2.9M |
|
|
GMIIU
3431
DELISTED
Gores Metropoulos II, Inc. Unit
GMIIU
| $2.92M | ﹤0.01% |
285,570
| – | – |
|
|
IRAAU
3432
DELISTED
Iris Acquisition Corp Units
IRAAU
| $2.91M | ﹤0.01% |
292,167
+3,254
| +1% | +$32.3K |
|
|
AUTL
3433
Autolus Therapeutics
AUTL
$623M
| $2.9M | ﹤0.01% |
443,431
-281,741
| -39% | -$1.78M |
|
|
SWTX
3434
DELISTED
SpringWorks Therapeutics
SWTX
| $2.9M | ﹤0.01% |
+45,757
| New | +$3.53M |
|
|
CMRX
3435
DELISTED
Chimerix, Inc.
CMRX
| $2.9M | ﹤0.01% |
468,293
-105,934
| -18% | -$728K |
|
|
YSAC
3436
DELISTED
Yellowstone Acquisition Company
YSAC
| $2.89M | ﹤0.01% |
285,121
+250,325
| +719% | +$2.52M |
|
|
PRSRU
3437
DELISTED
Prospector Capital Corp. Unit
PRSRU
| $2.89M | ﹤0.01% |
290,000
| – | – |
|
3438
Banco Santander Chile
BSAC
$16.6B
| $2.89M | ﹤0.01% |
146,168
-44,413
| -23% | -$874K |
|
|
TBLD
3439
Thornburg Income Builder Opportunities Trust
TBLD
$716M
| $2.89M | ﹤0.01% |
+144,057
| New | +$2.9M |
|
3440
Intapp
INTA
$3.33B
| $2.89M | ﹤0.01% |
112,068
-252,111
| -69% | -$8.19M |
|
3441
BCB Bancorp
BCBP
$156M
| $2.88M | ﹤0.01% |
195,406
-66,848
| -25% | -$975K |
|
3442
CALL
Kodiak Sciences
KOD
$2.37B
| $2.88M | ﹤0.01% |
30,000
| – | – |
|
3443
Community Health Systems
CYH
$413M
| $2.87M | ﹤0.01% |
245,185
-336,352
| -58% | -$4.39M |
|
3444
Kaltura
KLTR
$244M
| $2.87M | ﹤0.01% |
+278,794
| New | +$3.29M |
|
|
HLAH
3445
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
| $2.87M | ﹤0.01% |
295,392
-13,804
| -4% | -$134K |
|
3446
Jack Henry & Associates
JKHY
$12.1B
| $2.86M | ﹤0.01% |
17,459
-21,654
| -55% | -$3.72M |
|
|
TALKW
3447
CALL
DELISTED
Talkspace Inc Warrant
TALKW
| $2.86M | ﹤0.01% |
3,716,529
+1,769,637
| +91% | +$1.86M |
|
3448
Liberty Global Class C
LBTYK
$3.56B
| $2.86M | ﹤0.01% |
97,078
-83,344
| -46% | -$2.31M |
|
3449
Cars.com
CARS
$639M
| $2.86M | ﹤0.01% |
226,000
+186,082
| +466% | +$2.35M |
|
3450
Arlo Technologies
ARLO
$1.39B
| $2.86M | ﹤0.01% |
445,487
-366,092
| -45% | -$2.28M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.